US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case

Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the patents behind the lawsuit.